Glioblastoma multiforme (GBM) in the elderly: initial treatment strategy and overall survival.

about

Glioblastoma multiforme (GBM) in the elderly: initial treatment strategy and overall survival.

Item

http://www.wikidata.org/entity/Q38773618

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Glioblastoma multiforme (GBM) ...... strategy and overall survival.

@en

type

Item

label

Glioblastoma multiforme (GBM) ...... strategy and overall survival.

@en

prefLabel

Glioblastoma multiforme (GBM) ...... strategy and overall survival.

@en

P1476

Glioblastoma multiforme (GBM) ...... strategy and overall survival

@en

P2093

Goundappa K Balasubramani

http://www.w3.org/2001/XMLSchema#string

John C Flickinger

http://www.w3.org/2001/XMLSchema#string

Michael J Dohopolski

http://www.w3.org/2001/XMLSchema#string

Scott M Glaser

http://www.w3.org/2001/XMLSchema#string

P2860

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.

Treatment selection and outcomes in early-stage classical Hodgkin lymphoma: analysis of the National Cancer Data Base.

The National Cancer Data Base: a powerful initiative to improve cancer care in the United States

Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma.

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial.

P2888

s11060-017-2493-x

P304

107-118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-017-2493-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

134

http://www.w3.org/2001/XMLSchema#string

P50

Sushil Beriwal

P577

2017-05-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085441466

http://www.w3.org/2001/XMLSchema#string

P698

28527010

http://www.w3.org/2001/XMLSchema#string